Provided by Tiger Trade Technology Pte. Ltd.

Mereo Biopharma Group Plc

0.3360
-0.0066-1.93%
Post-market: 0.33790.0019+0.57%19:51 EDT
Volume:1.53M
Turnover:515.74K
Market Cap:53.47M
PE:-1.28
High:0.3460
Open:0.3340
Low:0.3293
Close:0.3426
52wk High:3.05
52wk Low:0.2000
Shares:159.13M
Float Shares:100.47M
Volume Ratio:0.91
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2629
EPS(LYR):-0.2627
ROE:-82.21%
ROA:-39.10%
PB:1.31
PE(LYR):-1.28

Loading ...

Mereo BioPharma Faces Securities Fraud Class Action Lawsuit

Reuters
·
Mar 04

Schall Law Firm Files Securities Fraud Class Action Against Mereo BioPharma Group plc

Reuters
·
Mar 03

Rosen Law Firm Sets April 6 Lead Plaintiff Deadline in Mereo BioPharma Securities Class Action

Reuters
·
Mar 03

European Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading

MT Newswires Live
·
Mar 03

Berger Montague files securities fraud class action against Mereo BioPharma Group plc

Reuters
·
Mar 02

European Equities Traded in the US as American Depositary Receipts Little Changed in Friday Trading

MT Newswires Live
·
Feb 28

Gross Law Firm Alerts Mereo BioPharma Investors to Pending Class Action Deadline April 6, 2026

Reuters
·
Feb 27

Faruqi & Faruqi Reminds Mereo BioPharma Investors of April 6, 2026 Lead Plaintiff Deadline

Reuters
·
Feb 26

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Feb 26

Critica drills into Jupiter as rare earths upgrade heats up

The West Australian
·
Feb 25

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

MT Newswires Live
·
Feb 25

Mereo BioPharma Faces Securities Class Action as Lead Plaintiff Deadline Nears

Reuters
·
Feb 24

Mereo BioPharma Faces Investor Lawsuit After Phase 3 Trial Failures Trigger Stock Plunge

Reuters
·
Feb 24

Rosen Law Firm Urges Mereo BioPharma ADS Investors to Act Before April 6 Lead Plaintiff Deadline

Reuters
·
Feb 21

Schall Law Firm Files Securities Fraud Class Action Against Mereo BioPharma Group plc

Reuters
·
Feb 21

Mereo BioPharma Faces Securities Class Action Ahead of April 6, 2026 Lead Plaintiff Deadline

Reuters
·
Feb 19

Mereo BioPharma Faces Nasdaq Delisting Risk Over Minimum Bid Price Rule

Reuters
·
Feb 18

Mereo BioPharma Faces Shareholder Class Action Over Alleged Misstatements

Reuters
·
Feb 17

Viridis Mining and Minerals Says Drilling Strengthens Resource Confidence at Brazil Project

MT Newswires Live
·
Feb 17

Mereo BioPharma Faces Class Action Over Failed Setrusumab Trials

Reuters
·
Feb 14